But as you originally wrote:
“Patients can record and then forward to their doctors their temperature and heart and lung sounds, allowing doctors to listen for lung findings associated with pneumonia and asthma,”
Sounds great right? But now imagine removing the $149 Purchase and being able to do this more accurately with no additional hardware and you start seeing the potential of “ResApp”..
Clearly, doctors might use the other product first, then decide that it isn't pneumonia or asthma, in which case Resapp won't get used. Certainly, as Resapp becomes available for other diseases, it would close the gap. Also, people on these threads have mentioned some doctors disliking the idea of a diagnostic coughing app, so those old-school doctors would be tempted to use the old product ahead of the app.
Dr Keating Email Interview, page-91
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Add to My Watchlist
What is My Watchlist?